Table of Content

Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in Coronavirus dealmaking

2.1. Introduction
2.2. Coronavirus partnering over the years
2.3. Coronavirus partnering by deal type
2.4. Coronavirus partnering by industry sector
2.5. Coronavirus partnering by stage of development
2.6. Coronavirus partnering by technology type
2.7. Coronavirus partnering by therapeutic indication

Chapter 3 –Financial deal terms for Coronavirus partnering

3.1. Introduction
3.2. Disclosed financials terms for Coronavirus partnering
3.3. Coronavirus partnering headline values
3.4. Coronavirus deal upfront payments
3.5. Coronavirus deal milestone payments
3.6. Coronavirus royalty rates

Chapter 4 – Leading Coronavirus deals and dealmakers

4.1. Introduction
4.2. Most active in Coronavirus partnering
4.3. List of most active dealmakers in Coronavirus
4.4. Top Coronavirus deals by value

Chapter 5 – Coronavirus contract document directory

5.1. Introduction
5.2. Coronavirus partnering deals where contract document available

Chapter 6 – Coronavirus dealmaking by therapeutic target

6.1. Introduction
6.2. Deals by Coronavirus therapeutic target

Appendices

Appendix 1 – Directory of Coronavirus deals by company A-Z 2014 to 2021
Appendix 2 – Directory of Coronavirus deals by deal type 2014 to 2021
Appendix 3 – Directory of Coronavirus deals by stage of development 2014 to 2021
Appendix 4 – Directory of Coronavirus deals by technology type 2014 to 2021
Further reading on dealmaking
Deal type definitions

About Wildwood Ventures

Current Partnering
Current Agreements
Recent report titles from CurrentPartnering

Table of figures

Figure 1: Coronavirus partnering since 2014
Figure 2: Coronavirus partnering by deal type since 2014
Figure 3: Coronavirus partnering by industry sector since 2014
Figure 4: Coronavirus partnering by stage of development since 2014
Figure 5: Coronavirus partnering by technology type since 2014
Figure 6: Coronavirus partnering by indication since 2014
Figure 7: Coronavirus deals with a headline value
Figure 8: Coronavirus deals with upfront payment values
Figure 9: Coronavirus deals with milestone payment
Figure 10: Coronavirus deals with royalty rates
Figure 11: Active Coronavirus dealmaking activity– 2014 to 2021
Figure 12: Top Coronavirus deals by value since 2014